Cannabis Products: FDA Asks Dosing, Research Incentive Questions
The public hearing on cannabis and cannabis-derivative products also included calls for Good Manufacturing Practices to be imposed.
You may also be interested in...
President Trump's budget request would boost compounding and vaccines by $5m, but human drugs program would lose $4.8m in training funds.
Deal with Pfizer makes for Theravance’s third large pharma partnership since 2016. AbbVie off-loads Marinol to India’s Alkem, Bausch licenses candidate for rare form of dry eye disease from Novaliq.
What do CBD advocates and anti-vaxxers have in common? A fundamental mistrust in the public health establishment. That should be a call to action for public health agencies and the biopharma industry.